12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Other News

Mayne Pharma, Warner Chilcott, Mylan infectious news

Warner Chilcott said the U.S. Court of Appeals for the Federal Circuit vacated a preliminary injunction granted by the U.S. District Court for the District of New Jersey prohibiting Mylan from selling a generic version of 150 mg Doryx doxycycline delayed-release tablets. The case was...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >